CX-072, a PD-L1 Probody Therapeutic, as Monotherapy in Patients With Advanced Solid Tumors: Preliminary Results of PROCLAIM-CX-072

Aung Naing, Fiona Thistlethwaite, Alexander Spira, Javier Garcia-Corbacho, Manreet Randhawa, Ferry ALM Eskens, Greg Durm, Nataliya Uboha, Omid Hamid, Anthony El-Khoueiry, Vanessa Huels, Will Garner, Beverly Benson, Hendrik-Tobias Arkenau, Patricia LoRusso. Poster presented at ASCO 2019, May 31-June 4, Chicago, Illinois.